{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:33:00Z","timestamp":1792765980244,"version":"4.5.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The COVID-19 pandemic changed the use of antibiotics and had an impact on the development of antimicrobial resistance. The study aimed to examine the consumption of antibiotics and the occurrence of AMR infection and colonization in the selected general hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data on antibiotic consumption and data on AMR infections and colonization were monitored in the period before the COVID-19 pandemic (2018, 2019) and during the COVID-19 pandemic (2020, 2021). Descriptive statistics, the Mann\u2013Whitney U test, and the Pearson or Spearman correlation test were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall prescription of antibiotics stayed approximately the same, however, some important differences can be observed when analyzing specific groups of antibiotics (vancomycin, linezolid, piperacillin\/tazobactam, meropenem, colistin). We did not observe the difference in the occurrence of AMR infections and colonizations before and during the pandemic. However, we did observe an alarming increase in CRaB, ESBL and VRE and highlighted the increase in all AMR groups between the first and second year of the pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The connection between antibiotic consumption and the occurrence of AMR infections and colonization was confirmed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1584574","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T05:21:22Z","timestamp":1750656082000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of the COVID-19 pandemic on the consumption of antibiotics and the emergence of AMR: case study in a general hospital"],"prefix":"10.3389","volume":"13","author":[{"given":"Ur\u0161ka","family":"Rozman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Kranjec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"\u0160eruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur\u0161ka","family":"Kramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Vrbnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Lavri\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja \u0160ostar","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref1","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"946077","DOI":"10.3389\/fpubh.2022.946077","article-title":"Effect of the COVID-19 pandemic on antibiotic consumption: a systematic review comparing 2019 and 2020 data","volume":"10","author":"Fukushige","year":"2022","journal-title":"Front Public Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jiph.2021.02.011","article-title":"Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand?","volume":"14","author":"Ghosh","year":"2021","journal-title":"J Infect Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/antibiotics12010045","article-title":"Increasing consumption of antibiotics during the COVID-19 pandemic: implications for patient health and emerging anti-microbial resistance","volume":"12","author":"Malik","year":"2022","journal-title":"Antibiotics"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"25 (45)","DOI":"10.2807\/1560-7917.Es.2020.25.45.2001886","article-title":"Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?","volume":"25","author":"Monnet","year":"2020","journal-title":"Euro Surveill"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"101848","DOI":"10.1016\/j.eclinm.2023.101848","article-title":"Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022","volume":"57","author":"Nandi","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jiph.2023.02.021","article-title":"A parallel and silent emerging pandemic: antimicrobial resistance (AMR) amid COVID-19 pandemic","volume":"16","author":"Rehman","year":"2023","journal-title":"J Infect Public Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"778386","DOI":"10.3389\/fphar.2021.778386","article-title":"Increased use of antibiotics in the intensive care unit during coronavirus disease (COVID-19) pandemic in a Brazilian hospital","volume":"12","author":"Silva","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40001-021-00539-1","article-title":"Effects of COVID-19 prevention procedures on other common infections: a systematic review","volume":"26","author":"Dadras","year":"2021","journal-title":"Eur J Med Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1038\/s41467-022-32663-9","article-title":"Designing isolation guidelines for COVID-19 patients with rapid antigen tests","volume":"13","author":"Jeong","year":"2022","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1056\/NEJMp2032369","article-title":"FDA approval of Remdesivir \u2014 a step in the right direction","volume":"383","author":"Rubin","year":"2020","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4014\/jmb.2110.10029","article-title":"COVID-19 Drug Development","volume":"32","author":"Kim","year":"2022","journal-title":"J Microbiol Biotechnol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coi.2021.07.003","article-title":"COVID-19 vaccines","volume":"71","author":"Ndwandwe","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/ice.2020.368","article-title":"Bacterial and fungal coinfections in COVID-19 patients hospitalized during the new York City pandemic surge","volume":"42","author":"Nori","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref16","volume-title":"Global antimicrobial resistance and use surveillance system (GLASS) report 2022","year":"2022"},{"key":"ref17","volume-title":"WHO global strategy for containment of antimicrobial resistance","year":"2001"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0272375","DOI":"10.1371\/journal.pone.0272375","article-title":"Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis","volume":"17","author":"Alshaikh","year":"2022","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/23744235.2020.1839672","article-title":"Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in the Netherlands","volume":"53","author":"Karami","year":"2021","journal-title":"Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"ofab236","DOI":"10.1093\/ofid\/ofab236","article-title":"Trends in antibiotic use in United States hospitals during the coronavirus disease 2019 pandemic","volume":"8","author":"Rose","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/s2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/antibiotics10070841","article-title":"Surveillance of antibacterial usage during the COVID-19 pandemic in England, 2020","volume":"10","author":"Andrews","year":"2021","journal-title":"Antibiotics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/antibiotics10080943","article-title":"Antimicrobial consumption among 66 acute care hospitals in Catalonia: impact of the COVID-19 pandemic","volume":"10","author":"Grau","year":"2021","journal-title":"Antibiotics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3390\/antibiotics10111405","article-title":"The impact of the SARS-Cov 2 pandemic on a persuasive educational antimicrobial stewardship program in a university hospital in southern Italy: a pre-post study","volume":"10","author":"Macera","year":"2021","journal-title":"Antibiotics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1017\/ice.2021.237","article-title":"Impact of the strategies implemented by an antimicrobial stewardship program on the antibiotic consumption in the coronavirus disease 2019 (COVID-19) pandemic","volume":"43","author":"Murgadella-Sancho","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e19723","DOI":"10.7759\/cureus.19723","article-title":"Assessment of the impact of COVID-19 on drug store Management in a Tertiary Care Teaching Hospital of Central India","volume":"13","author":"Padhan","year":"2021","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network \u2014 United States, march\u2013June 2020","volume":"69","author":"Tenforde","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.31729\/jnma.7394","article-title":"Antibiotics use in hospitalised COVID-19 patients in a tertiary care Centre: a descriptive cross-sectional study","volume":"60","author":"Thapa","year":"2022","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1080\/07391102.2020.1777904","article-title":"Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies","volume":"39","author":"Durojaiye","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"ref30","volume-title":"Surveillance of antimicrobial resistance in Europe 2017","year":"2018"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ajic.2020.10.019","article-title":"Unintended consequences of infection prevention and control measures during COVID-19 pandemic","volume":"49","author":"Wee","year":"2021","journal-title":"Am J Infect Control"},{"key":"ref32","year":"2024"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bcp.14461","article-title":"Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistance","volume":"87","author":"Cangini","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2020.1813024","article-title":"Azithromycin in the treatment of COVID-19: a review","volume":"19","author":"Echeverr\u00eda-Esnal","year":"2021","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0140-6736(21)00461-X","article-title":"Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"397","author":"Butler","year":"2021","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jmv.26441","article-title":"Bacterial infections and patterns of antibiotic use in patients with COVID-19","volume":"93","author":"Goncalves Mendes Neto","year":"2021","journal-title":"J Med Virol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3855\/jidc.14404","article-title":"Use of antibiotics in COVID-19 ICU patients","volume":"15","author":"Mustafa","year":"2021","journal-title":"J Infect Dev Ctries"},{"key":"ref38","author":"Wei","year":"2020"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12941-021-00444-9","article-title":"Repurposing of antibiotics for clinical management of COVID-19: a narrative review","volume":"20","author":"Yacouba","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.5114\/aoms\/152752","article-title":"Comparison of antibiotic use in the COVID-19 pandemic with the pre-pandemic period in a university hospital","volume":"18","author":"Erdem","year":"2022","journal-title":"Arch Med Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/antibiotics10060738","article-title":"Use of antimicrobials among suspected COVID-19 patients at selected hospitals, Bangladesh: findings from the first wave of COVID-19 pandemic","volume":"10","author":"Mah-E-Muneer","year":"2021","journal-title":"Antibiotics"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant gram-negative bacterial infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fpubh.2019.00151","article-title":"The \"old\" and the \"new\" antibiotics for MDR gram-negative pathogens: for whom, when, and How","volume":"7","author":"Karaiskos","year":"2019","journal-title":"Front Public Health"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.53986\/ibjm.2022.0020","article-title":"Rising incidence of carbapenem resistant isolates: an Argentinian hospital\u2019s experience. More trouble in the aftermath of the COVID-19 pandemic","volume":"4","author":"Castro","year":"2022","journal-title":"Iberoam J Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1900760","DOI":"10.2807\/1560-7917.Es.2021.26.15.1900760","article-title":"Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018","volume":"26","author":"Ramette","year":"2021","journal-title":"Euro Surveill"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jhin.2021.11.011","article-title":"Trend analysis of carbapenem-resistant gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions","volume":"120","author":"de Carvalho Hessel Dias","year":"2022","journal-title":"J Hosp Infect"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/j.ijantimicag.2021.106324","article-title":"Increased antimicrobial resistance during the COVID-19 pandemic","volume":"57","author":"Lai","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1017\/ice.2021.144","article-title":"Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: a multicenter before-and-after cross-sectional study","volume":"43","author":"Pascale","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/life11100996","article-title":"COVID-19 and antimicrobial resistance: data from the Greek electronic system for the surveillance of antimicrobial resistance-WHONET-Greece (January 2018-march 2021)","volume":"11","author":"Polemis","year":"2021","journal-title":"Life"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajic.2021.09.018","article-title":"Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil","volume":"50","author":"Polly","year":"2022","journal-title":"Am J Infect Control"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/antibiotics11050695","article-title":"An observational study of MDR hospital-acquired infections and antibiotic use during COVID-19 pandemic: a call for antimicrobial stewardship programs","volume":"11","author":"Shbaklo","year":"2022","journal-title":"Antibiotics"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13756-022-01114-x","article-title":"Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital","volume":"11","author":"Sinto","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1017\/s0950268811000744","article-title":"Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection","volume":"140","author":"Kim","year":"2012","journal-title":"Epidemiol Infect"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1016\/j.ijid.2010.02.2254","article-title":"A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Sheng","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/c5md00344j","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"Medchemcomm"},{"key":"ref58","volume-title":"WHO report on surveillance of antibiotic consumption: 2016\u20132018 early implementation","year":"2018"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref60","volume-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of Carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"976273","DOI":"10.1155\/2012\/976273","article-title":"Global fluoroquinolone resistance epidemiology and implictions for clinical use","volume":"2012","author":"Dalhoff","year":"2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37201\/req\/s02.01.2022","article-title":"Resistance to beta-lactams in gram-negative bacilli: relevance and potential therapeutic alternatives","volume":"35","author":"Garcia-Bustos","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.12688\/f1000research.14822.1","article-title":"Treatment of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?","volume":"7","author":"Pana","year":"2018","journal-title":"F1000Res"},{"key":"ref65","volume-title":"COVID-19: U.S. impact on antimicrobial resistance, special report 2022","year":"2022"},{"key":"ref66","volume-title":"WHO reports widespread overuse of antibiotics in patients hospitalized with COVID-19","year":"2024"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/antibiotics13060477","article-title":"The impact of SARS-CoV-2 pandemic on antibiotic prescriptions and resistance in a university hospital from Romania","volume":"13","author":"Zaha","year":"2024","journal-title":"Antibiotics"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1584574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T05:21:24Z","timestamp":1750656084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1584574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":67,"alternative-id":["10.3389\/fpubh.2025.1584574"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1584574","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"article-number":"1584574"}}